GeoVax Labs Statistics
Share Statistics
GeoVax Labs has 15.19M
shares outstanding. The number of shares has increased by 447.38%
in one year.
| Shares Outstanding | 15.19M |
| Shares Change (YoY) | 447.38% |
| Shares Change (QoQ) | 46.67% |
| Owned by Institutions (%) | 11.81% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 51,472 |
| FTD / Avg. Volume | 9.71% |
Short Selling Information
The latest short interest is 895.13K, so 5.89% of the outstanding
shares have been sold short.
| Short Interest | 895.13K |
| Short % of Shares Out | 5.89% |
| Short % of Float | 5.94% |
| Short Ratio (days to cover) | 1.85 |
Valuation Ratios
The PE ratio is -0.51 and the forward
PE ratio is -0.9.
GeoVax Labs's PEG ratio is
0.01.
| PE Ratio | -0.51 |
| Forward PE | -0.9 |
| PS Ratio | 3.24 |
| Forward PS | 0 |
| PB Ratio | 0 |
| P/FCF Ratio | -0.52 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for GeoVax Labs.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.55,
with a Debt / Equity ratio of 0.
| Current Ratio | 2.55 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1176.34 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $232,622.12 |
| Profits Per Employee | $-1,470,135.06 |
| Employee Count | 17 |
| Asset Turnover | 0.48 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -47.7% in the
last 52 weeks. The beta is 3.71, so GeoVax Labs's
price volatility has been higher than the market average.
| Beta | 3.71 |
| 52-Week Price Change | -47.7% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 2.22 |
| Relative Strength Index (RSI) | 41.26 |
| Average Volume (20 Days) | 529,893 |
Income Statement
In the last 12 months, GeoVax Labs had revenue of 3.95M
and earned -24.99M
in profits. Earnings per share was -4.82.
| Revenue | 3.95M |
| Gross Profit | 3.86M |
| Operating Income | -25.14M |
| Net Income | -24.99M |
| EBITDA | -24.88M |
| EBIT | -24.97M |
| Earnings Per Share (EPS) | -4.82 |
Full Income StatementBalance Sheet
The company has 5.51M in cash and 0 in
debt, giving a net cash position of 5.51M.
| Cash & Cash Equivalents | 5.51M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -129,356.1B |
| Total Assets | 10.83M |
| Working Capital | 7.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -24.68M
and capital expenditures 0, giving a free cash flow of -24.7M.
| Operating Cash Flow | -24.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -24.7M |
| FCF Per Share | -4.76 |
Full Cash Flow StatementMargins
Gross margin is 97.59%, with operating and profit margins of -635.83% and -631.98%.
| Gross Margin | 97.59% |
| Operating Margin | -635.83% |
| Pretax Margin | -631.98% |
| Profit Margin | -631.98% |
| EBITDA Margin | -629.03% |
| EBIT Margin | -635.83% |
| FCF Margin | -624.5% |
